Assessment of plasma β-Amyloid 1-42/1-40 ratio may help identify patients with Alzheimer’s Disease
Click here to learn more
Early Results from the BRCA Founder OutReach (BFOR) Study
Read more here
Which of your patients should be offered genetic testing for cancer risk in 2019?
Find out why our new PrEP Panel offering is a game changer!
Watch our video podcast here
Laboratory Blood-Based Testing for Lyme Disease at a National Reference Laboratory (2010-2016)
Read more here.
Non-invasive prenatal cell-free DNA screening
A recent study indicates high specificity and sensitiivity not only for women at high-risk, but also for women at average risk.
Screening for Sexually Transmitted Infections
Learn more by watching our short educational vignette here
Dr Jones and Dr Starolis will describe the various organisms and diseases that cause major tick-borne illnesses, the available testing options and which to choose... Read more ▸
Dr Gersh Identifies the chronic conditions that disproportionately impact women, explains the link between certain chronic conditions and women’s cardiometabolic risk and describes what steps... Read more ▸
Expert InsightsView All Expert Insights ▸
PublicationsView All Publications ▸
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Nanes BA, Laknezhad S, Chamseddin B, Doorbar J, Mir A, Hosler GA, Wang RC.
J Cutan Pathol. 2019 Oct 18. doi: 10.1111/cup.13599. [Epub ahead of print]
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Ihrler S, Mollenhauer M, Weitmayr B, Haas CJ.
Virchows Arch. 2019 Oct 15. doi: 10.1007/s00428-019-02657-y. [Epub ahead of print]
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Bril F, Clark VC, Soldevilla-Pico C, Firpi-Morell RJ, Lai J, Rowland CM, Cusi K
Diabetes Care 2019 Oct 11. doi: 10.2337/dc19-1071. [Epub ahead of print]
Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.
Br J Dermatol. 2019 Sep;181:580-583.
Pediatr Dermatol. 2019 Sep;36(5):718-719.
Am J Dermatopathol. 2019 Sep;41:652-654.